Semliki Forest virus (SFV) and Sindbis virus (SIN) are enveloped alphaviruses that enter cells via low-pHtriggered fusion in the endocytic pathway and exit by budding from the plasma membrane. Previous studies with cholesterol-depleted insect cells have shown that SFV requires cholesterol in the cell membrane for both virus fusion and efficient exit of progeny virus. An SFV mutant, srf-3, shows efficient fusion and exit in the absence of cholesterol due to a single point mutation in the E1 spike subunit, proline 226 to serine. We have here characterized the role of cholesterol in the entry and exit of SIN, an alphavirus quite distantly related to SFV. Growth, primary infection, fusion, and exit of SIN were all dramatically inhibited in cholesterol-depleted cells compared to control cells. Based on sequence differences within the E1 226 region between SFV, srf-3, and SIN, we constructed six SIN mutants with alterations within this region and characterized their cholesterol dependence. A SIN mutant, SGM, that had the srf-3 amino acid sequence from E1 position 224 to 235 showed increases of ϳ100-fold in infection and ϳ250-fold in fusion with cholesterol-depleted cells compared with infection and fusion of wild-type SIN. Pulse-chase analysis demonstrated that SGM exit from cholesteroldepleted cells was markedly more efficient than that of wild-type SIN. Thus, similar to SFV, SIN was cholesterol dependent for both virus entry and exit, and the cholesterol dependence of both steps could be modulated by sequences within the E1 226 region.
Alphaviruses such as Semliki Forest virus (SFV) and Sindbis virus (SIN) are simple enveloped viruses that have been particularly useful in studies of virus entry, membrane fusion, and virus biosynthesis and assembly. Alphaviruses are comprised of a nonsegmented positive-strand RNA genome associated with a capsid protein, a lipid bilayer derived from the plasma membrane during budding, and a spike protein containing two transmembrane polypeptides, E1 and E2, each about 50 kDa (14, 27) . Each virus particle contains 240 copies of E1 and E2 arranged as 80 trimers of E1/E2 heterodimers.
Alphaviruses enter cells by endocytic uptake in clathrincoated vesicles (5, 14) . The acid pH in endosomes triggers the fusion of the virus membrane with that of the endosome and releases the viral nucleocapsid into the cytoplasm to initiate infection (9, 10, 14) . The virus RNA is then translated and replicated, and new capsid proteins are synthesized in the cytoplasm and assembled with viral RNA into nucleocapsids (14, 27) . The spike polypeptides are translocated into the lumen of the endoplasmic reticulum and assembled into a dimer of E1 with the E2 precursor, which is termed p62 in SFV and PE2 in SIN. The p62/E1 dimer is transported via the cellular secretory machinery to the plasma membrane. In a late stage of the secretory pathway, the p62 (PE2) precursor is cleaved by furin-like proteases into E2 and E3. The latter is a small soluble protein that is secreted in SIN but that associates with the E1/E2 dimer as a peripheral protein in SFV (27) . At the plasma membrane, efficient budding is driven by both lateral interactions between viral spike proteins and an interaction between the E2 cytoplasmic tail and nucleocapsid (8, 9, 14, 27) .
A variety of evidence indicates that E1 is the fusogenic spike subunit and contains the virus fusion peptide (14, 16) . Studies of low-pH-dependent conformational changes in the SFV spike protein suggest an overall scheme for the E1-mediated fusion reaction (reviewed in references 9 and 14). Upon exposure to low pH, the normally stable E1/E2 dimer dissociates. The conformation of the E1 subunit then changes, exposing previously hidden sites for monoclonal antibody binding and forming a stable E1 homotrimer believed to be a key fusion intermediate. E1 associates with the target membrane (19) and mediates the mixing of the viral and target membranes.
In vitro fusion studies with liposomes have demonstrated that SFV fusion requires cholesterol (17, 29) and sphingolipid (23, 30) in the target membrane. The fusion-supporting activity of both lipids showed striking stereospecificity, suggesting specific roles in the fusion reaction. The role of cholesterol in vivo in SFV fusion and infection was investigated by depleting the C6/36 mosquito cell line of both free and esterified cholesterol to a level less than 2% of that of control cells (22, 24) . Studies of these cholesterol-depleted cells demonstrated that cholesterol is required not only for SFV fusion and infection but also for efficient SFV exit, while the unrelated virus vesicular stomatitis virus shows no cholesterol dependence for either fusion or exit. The cholesterol-depleted cells were used to isolate a cholesterol-independent SFV mutant termed srf-3 (sterol requirement in function). srf-3 is significantly increased in its ability to both fuse with and exit from cholesterol-depleted cells (22, 28) . A single point mutation in E1, proline 226 to serine, was shown to be responsible for the srf-3 phenotype in both fusion and exit (28) .
To date, SFV is the only virus that has been demonstrated to require cholesterol for membrane fusion and exit. To examine whether a cholesterol requirement is a general property of the alphavirus life cycle, we characterized the role of cholesterol in the entry and exit pathway of SIN, an alphavirus distantly related to SFV (27) . Our results demonstrated that despite the sequence differences between SFV and SIN, SIN was also highly dependent on cellular cholesterol for infection, fusion, and exit. Specific mutations in the 226 region of SIN E1 decreased the cholesterol dependence of SIN fusion and exit, suggesting that, similar to the situation with SFV, this region of E1 is involved in the virus cholesterol requirement.
(This research was conducted by Yanping E. Lu in partial fulfillment of the requirements for a Ph.D. degree from the Sue Golding Graduate Division of Medical Sciences, Albert Einstein College of Medicine, Yeshiva University, Bronx, N.Y.)
MATERIALS AND METHODS
Cells and viruses. C6/36, a clonal mosquito cell line derived from Aedes albopictus, was cultured at 28°C in Dulbecco's modified Eagle's medium with 100 U of penicillin/ml and 100 g of streptomycin/ml (DME) and containing 10% heatinactivated fetal calf serum (HIFCS) (22) . Cholesterol-depleted C6/36 cells were prepared by at least four passages in DME containing 10% Cab-O-Sil-delipidated HIFCS as previously described (22, 24, 28) and used between passage 5 and passage 15 to avoid potential adaptation (21) . C6/36 cells depleted by this method had both free and esterified cholesterol levels of less than 2% of those of control cells (22, 24) . BHK-21 cells were used for plaque titration and preparation of virus stocks and were cultured at 37°C in DME containing 5% FCS and 10% tryptose phosphate broth (24) .
Wild-type SFV was derived from a plaque-purified isolate (18) . srf-3 is an SFV mutant selected for growth on cholesterol-depleted C6/36 cells and shown to be much less dependent on cellular cholesterol for infection, fusion, and exit (22, 28) . Wild-type (wt) SIN and all SIN mutants were derived from the infectious clone Toto 1101 (25) . All virus stocks were stored at Ϫ80°C in medium containing 10 mM HEPES (pH 7.4).
In vitro mutagenesis and generation of virus stocks. Mutations were introduced into the Toto 1101 infectious clone by PCR mutagenesis using Pfu DNA polymerase (Stratagene, La Jolla, Calif.) and the overlap extension method (28) . Mutagenic primer pairs were designed not only to carry the desired mutations ( Fig. 1 ) but also to insert a new restriction enzyme digestion site used as an initial screen of mutant infectious clones. Unique BsiWI and XhoI sites at positions 10382 and 11748 were used for subcloning the mutations into the Toto 1101 infectious clone, and the sequence of this region from each mutant infectious clone was determined by the automated sequencing facility of the Albert Einstein College of Medicine to confirm the presence of the desired mutations and the absence of other mutations due to PCR error. To generate wild-type and mutant virus stocks, infectious clones were linearized by XhoI digestion, infectious RNAs were synthesized by in vitro transcription, 10 to 20 g of RNA was introduced into BHK cells by electroporation, and the cells were cultured for ϳ18 h at 37°C (6, 28) .
Assays of virus infection, fusion, and growth. In general, infection of cells by SFV and SIN was carried out by prebinding viruses to control or cholesteroldepleted C6/36 cells on ice for 60 to 90 min in RPMI medium without bicarbonate but supplemented with 10 mM HEPES and 0.2% bovine serum albumin (BSA) (21, 22 4 Cl, and quantitation of infected cells by indirect immunofluorescence was performed as described above (28) . The infection resulting from pH 7 incubation was Ͻ0.1% of that resulting from acid pH treatment.
Assays of virus exit. Pulse-chase analysis of C6/36 cells in 35-mm plates was used to monitor the release of newly synthesized SIN viruses, using methods similar to those previously published for SFV exit (22) . Previous studies have demonstrated that this assay accurately reflects the release of virus particles (22, 28) . Briefly, control cells were infected with wt SIN or SGM at 10 PFU/cell for ϳ22 h at 28°C. Cholesterol-depleted cells were infected with wt SIN or SGM by transfecting with in vitro-transcribed RNA to bypass the cholesterol-dependent infection block. Two and a half micrograms of infectious RNA was mixed with 10 g of Cellfectin (Gibco/BRL) in 1 ml of Opti-MEM without antibiotics, incubated at room temperature for 30 to 45 min, and then incubated with cholesteroldepleted cells for 35 S]methionine-cysteine/ml (depleted cells) and chased in minimal essential medium containing a 10-fold excess of methionine and cysteine. At each time point, the chase medium was harvested in the absence of detergent, and the cells were lysed in a buffer containing Triton X-100 and protease inhibitors (22) . Cell lysates were precipitated with rabbit polyclonal antibodies raised against SIN spike proteins (from Milton Schlesinger, Washington University School of Medicine). The medium samples were precipitated in the absence of detergent with a monoclonal antibody against E2 (SV209 [26] , from Richard Kuhn, Purdue University) that efficiently precipitates the virus particle (data not shown). As indicated in the figure legends, different amounts of cell lysate and medium samples were used for immunoprecipitation in order to better visualize protein expression and virus release. Antibody concentrations were adjusted to completely precipitate the virus spike proteins present in each sample (data not shown). Samples were reduced and alkylated (15) and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 10.8% acrylamide gels followed by fluorography and phosphorimaging (ImageQuant v. 1.2; Molecular Dynamics, Inc., Sunnyvale, Calif.).
RESULTS
SFV has been shown to require cellular cholesterol for infection, fusion, and exit (22, 24) , and the cholesterol dependence of both SFV entry and exit are markedly decreased by the point mutation E1 P2263S (28) (Fig. 1 ). E1 residue 226 varies among the reported sequences of various alphaviruses, being alanine in a number of alphaviruses, including SIN, the prototype alphavirus, or valine in the case of western equine encephalitis virus, Highlands J virus, and one recently reported SIN strain. Given the availability of SIN infectious clones, useful antibody reagents, background information on SIN infection, and the considerable evolutionary distance from SIN to SFV (27), we chose SIN as a system to evaluate the general significance of cholesterol in alphavirus fusion and exit. Our test SIN strain was derived from the widely used Toto 1101 infectious clone (25) and contains alanine at E1 position 226.
The role of cellular cholesterol in SIN infection, fusion, and growth. The growth rates of SIN, SFV, and srf-3, the SFV mutant containing P2263S, were compared on control and cholesterol-depleted C6/36 mosquito cells at a multiplicity of 1 PFU/cell. Production of progeny virus from control cells was very rapid and efficient for all three viruses, although the growth of SIN was somewhat slower than that of SFV and srf-3. SFV and srf-3 titers increased from ϳ10 3 to ϳ10 9 PFU/ml during the first 11 h of infection, while SIN titers increased from ϳ10 4 to ϳ10 7 PFU/ml during this period and reached a titer of 10 9 PFU/ml after ϳ24 h of infection ( Fig. 2A) . The slightly slower growth kinetics of SIN may be due to the fact that a given multiplicity of SIN, as titrated on BHK cells, shows less infectivity on mosquito cells than a comparable amount of SFV (data not shown). In contrast to their efficient growth on control C6/36 cells, both SFV and SIN displayed very inefficient growth in cholesterol-depleted cells, showing little (SFV) or no (SIN) increase in titer even after 48 h of infection (Fig.  2B) . Although the cholesterol-independent mutant srf-3 grew more slowly in the absence of cholesterol, it reached final titers of ϳ10 9 PFU/ml after ϳ34 h of infection, similar to previous results (28) . Thus, analysis of virus growth properties indicated that SIN, similar to SFV, had a strong requirement for cholesterol in the cell membrane during the virus life cycle, while the srf-3 mutant was substantially less cholesterol dependent than either SFV or SIN.
Previous studies of SFV and srf-3 demonstrated that the virus cholesterol requirement for growth was due to the requirement for cholesterol in two steps in the virus life cycle, fusion and exit (22, 24, 28) . To resolve cholesterol-dependent events during SIN entry, we measured infectivity and fusion of SIN on control and cholesterol-depleted cells. Primary infection levels of SIN, SFV, and srf-3 were assayed in parallel (Fig.  3A) , and in keeping with previous results, wt SFV infection of depleted cells was decreased by about 4 logs compared to its infection of control cells (22, 28) . In contrast, srf-3 infection of depleted cells was increased ϳ100-fold compared to the level for wt SFV. Strikingly, SIN primary infection displayed an even stronger cholesterol requirement than that of wt SFV, showing a decrease of ϳ5 logs in infection of depleted cells compared to control cells (Fig. 3A) . This stronger sterol requirement for SIN infection probably at least partially explains the somewhat stronger SIN growth defect in depleted cells (Fig. 2B) .
The decreased infection of depleted cells by SIN could conceivably be due to alterations in virus binding to the cell surface receptor, endocytic uptake, endosome acidification, and/ or virus fusion with endosome membranes. Previous studies showed that the decrease in infection by SFV in depleted cells is due to a decrease in virus fusion, while receptor binding, endocytosis, and endosome acidification are unaffected (24) . In order to examine whether a similar fusion block explained the decrease in SIN infection, levels of SIN, wt SFV, and srf-3 fusion were compared on control and depleted cells (Fig. 3B) . In agreement with our previous results (28) , wt SFV fusion with cholesterol-depleted cells was reduced by ϳ5 logs compared to fusion with control cells. While the srf-3 mutant showed maximal fusion on control cells, it fused about 1,000-fold more efficiently with depleted cells than did wt SFV. SIN showed a cholesterol dependence for membrane fusion similar to that of wt SFV, suggesting that the strong block in SIN infection in the absence of cholesterol was due to a block in SIN fusion with the endosome membrane of depleted cells.
Rationale for mutagenesis of the SIN E1 226 region. The single point mutation at position 226 (P3S) makes srf-3 much less cholesterol dependent than wt SFV for both fusion and exit (28) . We compared the sequences of the E1 226 region between SFV and SIN (Fig. 1) . The 12 amino acids from position 224 to 235 are identical between the two viruses except for the residues proline 226 -glycine 227 -methionine 228 (PGM) in SFV, which are alanine-lysine-asparagine (AKN) in SIN. Given the similar, highly cholesterol-dependent phenotypes of SFV and SIN, we wished to test whether the SIN E1 226 region plays a role in its cholesterol dependence. We therefore constructed two SIN mutants, containing either the P2263S point mutation on the SIN background or a change of the SIN AKN sequence to SGM to give the srf-3 sequence from residues 224 to 235 (Fig. 1) . The mutants will be referred to as SKN or SGM, with the amino acid sequence from position 226 to 228 listed and changes from the wild-type SIN sequence underlined. To obtain virus stocks, SKN and SGM RNAs were prepared from the corresponding infectious cDNA clones and transfected into BHK cells and infection was allowed to proceed for 18 h. Transfection of RNA containing either mutation resulted in efficient primary and secondary infection in BHK cells and production of high-titered virus stocks (data not shown). This result suggests that the SKN and SGM mutations did not affect SIN spike protein folding, virus exit, or fusion in cells with cholesterol and is in keeping with the fact that the srf-3 mutation (P226S) does not affect SFV infection on cholesterol-containing BHK or C6/36 cells (28) . Electron micros- copy of infected control C6/36 cells also demonstrated that the SGM mutant showed overall morphology, targeting, and budding characteristics similar to those of the wt virus, with one capsid per particle and budding virions observed primarily at the cell plasma membrane (data not shown).
Cholesterol requirements for growth, infection, and fusion of wt and SIN mutants. The growth properties of SIN, SKN, and SGM were compared in control and cholesterol-depleted C6/36 cells. In control cells (Fig. 4A) , both mutants produced progeny virus with kinetics similar to those of wt SIN, with titers of ϳ10 9 PFU/ml (wt and SKN) and ϳ2 ϫ 10 8 PFU/ml (SGM) 24 h after infection. The titers of SGM at 24 and 48 h were consistently about fivefold lower than those obtained with wt or SKN on control cells. It is not clear if this is due to less efficient plaque production on BHK cells or less efficient growth of SGM on C6/36 cells. Neither wt SIN nor the SKN mutant showed any progeny virus production on depleted C6/36 cells (Fig. 4B) . The virus titer in the medium actually decreased during the incubation, presumably due to cellular inactivation of input virus. In contrast, although not as efficient as its growth on control cells or as the growth of srf-3 on depleted cells, the SGM mutant showed significantly increased progeny virus production in sterol-depleted cells, with a final titer of ϳ10 6 PFU/ml after 48 h of infection. The infectivity of wt and mutant SIN was compared on control and depleted C6/36 cells (Fig. 5A ). Both wt SIN and the SKN mutant infected depleted cells very poorly, with an almost 6-log decrease in infectivity on depleted cells compared to control cells. In contrast, although still about 1,000-fold less efficient than its infection of cholesterol-containing cells, the SGM mutant infected depleted cells ϳ100-fold better than wt SIN. This increase in SGM primary infection was due to an increase of about 250-fold in the fusion of SGM with the cholesterol-depleted cell membrane compared to the level for wt virus (Fig. 5B) . Fusion of the SKN mutant with cholesterol-depleted membranes was greatly impaired, similar to the level for wt levels. These data indicate that, in contrast to results with the srf-3 mutation of SFV, the introduction of 226S in the context of SIN E1 was insufficient for production of a cholesterol-independent fusion phenotype. However, mutations that substituted the srf-3 sequence from E1 residues 224 to 235 conferred a striking reduction in the cholesterol requirement for SIN fusion and infection.
Cholesterol dependence of SIN and SGM exit. Our previous data indicated that wt SFV, which was cholesterol dependent for fusion, was also cholesterol dependent for exit, while the srf-3 mutant was less cholesterol dependent for both fusion and exit (22, 28) . To correlate the SIN cholesterol requirement for fusion with that for exit, pulse-chase analysis was performed in control and sterol-depleted C6/36 cells. Control cells were infected with either wt SIN or the SGM mutant, pulse-labeled with [
35 S]methionine-cysteine, and chased for various times. The amount of newly synthesized viral spike proteins in the cells and the amount released as virus particles in the medium were evaluated at each time point (Fig. 6A) . Immediately following the 15-min pulse-labeling (0 h), several processed forms of PE2 and E1 from both wt SIN and SGM were observed (e.g., a PE2 doublet). With increasing time of chase, PE2 was cleaved to E2 and E3 and increasing amounts of assembled virus were released into the medium. Phosphorimaging was used to quantitate the percentage of total labeled spike proteins released into the medium (Fig. 6A) . Virus release within a 4-h chase was ϳ17% for wt spike proteins and ϳ10% for SGM, a difference that appeared to be due to experimental variation. Thus, exit efficiencies of wt SIN and SGM from control cells were similar.
Given the strong block in fusion in the absence of cholesterol, depleted C6/36 cells were infected with SIN or SGM using RNA transfection (see Materials and Methods). Transfected cells were pulse-labeled for 30 min and chased for the indicated times, and the percentage of virus release was determined (Fig. 6B) . Both wt SIN-and SGM-infected cells produced abundant viral spike proteins and showed similar kinetics of PE2 cleavage. Similar to the results with SFV, almost no wt SIN virus was released even after 6 h of chase (ϳ1% of total spike proteins released during 6 h). In contrast, the SGM mutant was released from depleted cells with kinetics similar to those of control cells (ϳ14% of total spike proteins released within 6 h). Thus, wt SIN shows a cholesterol requirement for fusion and exit similar to the results previously observed with wt SFV, while the SGM mutant is relatively cholesterol independent for both entry and exit.
Mutations responsible for decreased SIN cholesterol dependence. Our results demonstrated that the SGM mutant was markedly less cholesterol dependent for both virus fusion and exit than either wt SIN or the SKN point mutant. Selections for additional cholesterol-independent mutants of SFV have independently yielded the srf-3 P2263S mutation eight times, suggesting the importance of the serine substitution (3). We therefore predicted that the cholesterol-independent phenotype of the SGM mutant was due to the combination of serine with glycine and/or methionine. Four additional SIN mutants were constructed to evaluate the importance of serine and the adjacent residues (Fig. 1) . The SGN and SKM mutants were used to test the effect of serine 226 in combination with either glycine 227 or methionine 228 . The mutant AGM retained the SIN alanine at position 226 but substituted the SFV glycine 227 -methionine 228 . We also constructed the mutant PGM, which has the wt SFV sequence from residues 224 to 235 on the SIN background. RNAs containing the mutations were prepared from the cDNA clones and transfected into BHK cells to obtain virus stocks. All four additional mutant constructs resulted in high-titer virus stocks capable of carrying out efficient secondary infection on BHK cells (data not shown), again indicating their lack of deleterious effects on spike protein folding, assembly, and normal fusion function. Efficiencies of infection of control and sterol-depleted C6/36 cells by wt SIN, SGM, and the new mutants were then compared in parallel (Fig. 7) . As expected, wt SIN showed a strong cholesterol requirement, with a difference of about 5 logs between infection of depleted versus control cells. The SGM mutant was increased ϳ100-fold in its ability to infect depleted cells. Both the SGN and AGM mutants were significantly increased over wt SIN in their ability to infect in the absence of cellular cholesterol, with increases of ϳ500-fold and 60-fold, respectively. The SKM mutant showed no increase from wt SIN in infectivity on depleted cells. Similarly, the presence of the wt SFV sequence PGM in the SIN background caused a highly cholesterol-dependent phenotype, with a difference of ϳ5.5 logs in infectivity of the PGM mutant between control and depleted cells. Thus, while a strong increase in virus infection of cholesterol-depleted cells resulted from the combination of serine 226 with either glycine 227 -methione 228 or glycine 227 -asparagine 228 , the serine was not strictly required for increased cholesterol independence as the glycine 227 -methione 228 substitution also increased virus ability to infect sterol-depleted cells. A requirement for the serine hydroxyl group in conferring cholesterol independence was thus not observed. Neither serine 226 nor glycine 227 alone was sufficient to reduce cholesterol dependence, since both the SKN and PGM mutants were highly cholesterol dependent. These results indicate that, similar to SFV, sequences in the SIN 226 region affect virus cholesterol dependence, and they suggest that the overall conformation of this region, rather than specific amino acid side chains, is involved in the virus sterol requirement. 
DISCUSSION
Virus membrane fusion and virus budding are two critical steps in the life cycles of enveloped animal viruses and represent possible sites for intervention by antiviral therapy. Membrane fusion is catalyzed by the virus spike proteins, which change their conformation to a fusogenic form in which the viral hydrophobic fusion peptide is exposed and interacts with the target membrane (11) . While this general scheme appears common to all virus fusion reactions, different viral fusion proteins use different mechanisms to trigger fusion. For example, the fusogenic conformational changes in the influenza virus spike protein require low pH (13) , those of avian leukosis and sarcoma virus require spike-receptor interaction (12) , and in the case of HIV-1, virus fusion is triggered by a mechanism that requires interaction with both the CD4 receptor and a 7-transmembrane, G protein-coupled coreceptor (1, 7). Similarly, virus budding is the general means by which viruses acquire a membrane envelope, but this reaction varies markedly in the intracellular site of budding, the viral components required to support budding, and the mechanisms involved (8) . Alphaviruses are similar to many other viruses in having a fusion reaction that is triggered by low pH and a budding reaction that occurs at the plasma membrane. Interestingly, both of these steps in the alphavirus life cycle are greatly enhanced by the presence of cholesterol in the cell membrane. Thus, studies of alphaviruses have identified lipids as possible cofactors for critical steps in infection and progeny virus production.
We have here characterized the cholesterol dependence of SIN, the prototype member of the alphaviruses. Similar to SFV, SIN strongly required cellular cholesterol for fusion, infection, and virus exit. The SIN strain we used in this study is derived from the Toto 1101 infectious clone, a hybrid of HRsp strain-derived sequences (nsP1, partial nsP2, C-terminal region of PE2, 6K, and E1) and HR strain-derived sequences (partial nsP2, nsP3, nsP4, capsid, and most of PE2) (25) . Previous studies showed that infection of cells by Toto 1101 occurs via acid-pH-induced fusion, with an apparent fusion threshold that is somewhat more acidic than that of wt SFV and therefore with a lower K i for two endosomal acidification inhibitors, ammonium chloride and bafilomycin A-1 (10) . Although the precise pH value required for fusion and infection thus differs between wt SFV and the SIN strain used here, the cholesterol dependence of virus fusion and exit was significant and comparable between the two viruses. Moreover, as predicted from the location of the SFV srf-3 mutation, mutations in the E1 226 region of SIN decreased the cholesterol dependence of virus fusion, suggesting that this region is also involved in the SIN cholesterol requirement. Interestingly, the SGM mutant, which is less cholesterol dependent for growth, infection, and fusion than wt SIN, is also less cholesterol dependent for virus exit. This is in keeping with our previous results, which suggested a correlation between the relative cholesterol dependence of virus fusion and virus exit (22, 28) . In SFV, the cholesterol requirement for exit can be localized to a late stage of virus exit, subsequent to spike protein arrival at the plasma membrane (20) , and similarly, we presume that SIN also needs cholesterol for a late step in virus exit from the plasma membrane. Although the exact relationship between the sterol requirement for fusion and exit is as yet unclear, the results to date suggest that sterol-E1 interactions are involved in both virus fusion and exit and that mutations that decrease the stringency of the sterol requirement for fusion similarly affect the requirement for virus exit.
Our mutagenesis results indicate that several sequences in the 226 region can increase SIN cholesterol independence, including 226 SGM, 226 SGN, and 226 AGM. Interestingly, a subset of alphaviruses, including strains of eastern equine encephalitis virus and Venezuelan equine encephalitis virus, contain 226 AG in combination with alternative amino acids at position 228 and elsewhere in the 224 to 235 region (28) . The alphavirus Barmah Forest virus contains the sequence 226 SGN and has the same sequence as the SIN SGN mutant throughout the 224 to 235 region save for the single exception of alanine at position 225. Given the significant overall sequence divergence among alphaviruses and the limited available functional information, we cannot draw conclusions about the cholesterol dependence of other alphaviruses. It is clear, however, that SIN and SFV, which are distantly related members of the alphaviruses (27) , are both highly cholesterol dependent, suggesting that all members of the alphaviruses may have a cholesterol requirement for virus entry and exit. The reason for the cholesterol requirement in SFV and SIN infection is not known, but it is interesting that although selection for growth on cholesterol-depleted cells yields SFV mutants with strikingly lower cholesterol requirements, such mutants still have a strong preference for cholesterol-containing membranes as fusion targets (3, 28) . In contrast, unrelated viruses, such as vesicular stomatitis virus, can support low-pH-dependent fusion, infection of both mammalian and insect cells, and plasma membrane-localized budding in the absence of a sterol requirement (4, 22, 24) .
Previous studies of SFV fusion with liposomes demonstrated that sterol analogues could sustain efficient fusion even though the available biophysical evidence indicated that these analogues were inactive in affecting membrane fluidity or in associating with phospholipids (17) . The key sterol structural feature for supporting fusion was the sterol 3␤-hydroxyl group (17, 24) . Experiments with the E1 ectodomain of SFV revealed a critical role for 3␤-hydroxysterol in potentiating low-pHdependent conformational changes in E1, E1 trimer formation, and E1 insertion into lipid bilayers (19) . Recent biochemical studies of srf-3 have demonstrated that the P226S mutation acts to increase the relative cholesterol independence of the fusogenic conformational changes in E1, including homotrimer formation (2) . Taken together, these results suggest that the alphavirus cholesterol requirement probably reflects a role for cholesterol in inducing or maintaining the optimal E1 conformation(s) necessary for virus fusion and exit. 6 infectious centers/ml on control cells. Data are the averages of two independent experiments, and error bars show the ranges.
